Patient preferences in the treatment of stage III/IV classic Hodgkin lymphoma: Results from the CONNECT cross‐sectional survey

Documenti analoghi

• External validation and calibration of the HoLISTIC Consortium's advanced‐stage Hodgkin lymphoma international prognostic index (A‐HIPI) in the Brazilian Hodgkin lymphoma registry
  di: Valeria Buccheri, et al.
  Pubblicazione: (2024)
• Refining the risk stratification in advanced‐stage classical Hodgkin lymphoma: A critical analysis of clinical prediction models
  di: Oguzhan Koca, et al.
  Pubblicazione: (2025)
• Toward a paradigm shift in prognostication and treatment of early‐stage Hodgkin lymphoma
  di: Andrea Gallamini, et al.
  Pubblicazione: (2024)
• The importance of assessing the fitness of older patients with newly diagnosed diffuse large B‐cell lymphoma and classic Hodgkin lymphoma
  di: Vittorio Ruggero Zilioli, et al.
  Pubblicazione: (2025)
• Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma
  di: Thomas M. Kuczmarski, et al.
  Pubblicazione: (2024)